Impact of inactive empiric antimicrobial therapy on inpatient mortality and length of stay.
about
Delays in appropriate antibiotic therapy for gram-negative bloodstream infections: a multicenter, community hospital studyImpact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study.Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes.Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis.Clinical and microbiological characteristics of bloodstream infections due to AmpC β-lactamase producing Enterobacteriaceae: an active surveillance cohort in a large centralized Canadian region.Incidence and outcome of inappropriate in-hospital empiric antibiotics for severe infection: a systematic review and meta-analysis.Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia.Effect of differences in MIC values on clinical outcomes in patients with bloodstream infections caused by gram-negative organisms treated with levofloxacin.Morbidity associated with Pseudomonas aeruginosa bloodstream infections.Life-years gained with meropenem over ciprofloxacin in penicillin-allergic patients with gram-negative bacilli sepsis: results of a probabilistic model.The role of antimicrobials in the treatment of sepsis and critical illness-related bacterial infections: examination of the evidence.Between community and hospital: healthcare-associated gram-negative bacteremia among hospitalized patients.
P2860
Q28534034-AC10592A-D981-409F-B18E-A2A7EACE47CDQ33369556-14D80015-3CE2-46E3-8D9C-B14BF560A35FQ33988563-6C667AA8-B676-44C4-A02C-808288064D13Q34529198-FE62882F-2DCE-4565-94BE-5AD6D717CD9BQ34987739-053F97B6-6BE7-4778-BB13-FCF9EB9AC078Q35174295-0880C58D-3677-4F95-A0A2-081BC68DAB3FQ36870904-DCD3FD86-3A58-4186-8917-6A0B79AFF1C9Q37115679-BA9AA7B4-4E09-49BF-B342-B4262DF5FC25Q37219943-6355778E-F73D-4BF2-BDAF-185A8E60A941Q37933361-9A5BCA88-E71C-4F6C-82D7-9F945F9E35FCQ38307809-63E44437-8F8F-4131-9EF8-1DAAE539901AQ42635619-B5C6868A-4FDF-4D6A-BB29-2DD5E2574582
P2860
Impact of inactive empiric antimicrobial therapy on inpatient mortality and length of stay.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Impact of inactive empiric ant ...... mortality and length of stay.
@ast
Impact of inactive empiric ant ...... mortality and length of stay.
@en
type
label
Impact of inactive empiric ant ...... mortality and length of stay.
@ast
Impact of inactive empiric ant ...... mortality and length of stay.
@en
prefLabel
Impact of inactive empiric ant ...... mortality and length of stay.
@ast
Impact of inactive empiric ant ...... mortality and length of stay.
@en
P2093
P2860
P356
P1476
Impact of inactive empiric ant ...... t mortality and length of stay
@en
P2093
Gary A Noskin
Joe M Feinglass
Maureen K Bolon
Michael J Postelnick
P2860
P304
P356
10.1128/AAC.00466-06
P407
P577
2006-10-01T00:00:00Z